ETV5 and hepatocellular carcinoma: In hepatocellular carcinoma (HCC), YTHDF2 facilitates the m6A-dependent translation of ETS variant transcription factor 5 (ETV5), which induces PD-L1 transcription and suppresses CD8 + T-cell-mediated antitumor immunity [116].